- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06879431
Preoperative Sleep Intervention on Postoperative Delirium in School-aged Children Undergoing Congenital Heart Surgery
The Impact of Cognitive Behavioral Intervention On Postoperative Delirium In School-aged Children With Sleep Disorder Undergoing Congenital Heart Surgery: A Multicenter, Randomized Controlled Clinical Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
The study will be carried out in Fuwai Hospital, Chinese Academy of Medical Sciences, Anzhen Hospital Affiliated to Capital Medical University, Fuwai Central China Cardiovascular Hospital, Fuwai Cardiovascular Hospital of Yunnan Province, and Children's Hospital Affiliated to Capital Institute of Pediatrics.
The research process is as follows: Conduct a routine assessment of sleep disorders for the children visiting the outpatient clinic. The guardians fill out the online Children's Sleep Habits Questionnaire. Fully inform the children with sleep disorders and their guardians of all the contents and procedures of this trial. After obtaining informed consent and signing the informed consent form, conduct a further assessment on the children to determine whether they meet the inclusion and exclusion criteria. All enrolled children and their guardians will receive preoperative education for congenital heart disease in the outpatient clinic. After stratification by research center, the random block is set to 4 - 6, the R will be used to randomly assign subjects to the experimental group and the control group at a 1:1 ratio. After randomization, the parents of children in the experimental group register for a WeChat mini-program, and the children receive cognitive-behavioral interventions every day before surgery. Guardians need to strictly implement and cooperate with researchers through phone calls (during the waiting period for admission) or face-to-face communication (during the preoperative hospitalization period). The control group does not receive any intervention and follows routine clinical practice. To better control the quality of interventions for children aged 6 - 12 in the experimental group, the daily implementation status of parents is counted for the degree of implementation (0 - 100%) in the WeChat mini-program. Guardians record the children's daily sleep diaries (online questionnaires) before surgery. The day before surgery, parents fill out the online Children's Sleep Habits Questionnaire again and compare the scores with the baseline scores. After admission, children wear actigraphs until the day of surgery and until discharge after surgery to automatically record sleep-related information. After the children are enrolled in the study, relevant researchers will supervise the implementation of cognitive-behavioral interventions for the children once a day before surgery to ensure that the actigraph device functions properly during hospitalization and remind guardians to record electronic sleep diaries until the night before surgery. Follow-up will be conducted within 7 days after surgery or before discharge to evaluate outcomes such as delirium and pain. The primary outcome is the incidence of postoperative delirium, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fuxia Yan
- Phone Number: 010 88396628
- Email: yanfuxia@sina.com
Study Locations
-
-
-
Beijing, China, 100037
- Recruiting
- Fuwai Hospital, Chinese Academy of Medical Sciences
-
Contact:
- Fuxia Yan
- Phone Number: +861088396628
- Email: yanfuxia@sina.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 0-36 months
- Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.
- Sleep disorder assessed by Children's Sleep Habits Questionnaire (CSHQ) (CSHQ score >48)
Exclusion Criteria:
- Preoperative use of sleep therapy-related medications
- The risk adjustment in congenital heart surgery-1 (RACHS-1 classification) ≥4
- History of preoperative cardiac assist device, mechanical ventilation support, or asphyxia rescue
- Emergency surgery or preoperative ICU admission
- History of neurodevelopmental disorders such as autism spectrum disorder, attention deficit hyperactivity disorder, or psychiatric disorders such as depression
- Combined severe hepatic and renal dysfunction
- Combination of non-cardiac malformations (adenoid hypertrophy, tracheobronchial stenosis, polysplenism, anaplastic syndrome, Down syndrome, DiGeoge syndrome, diabetes mellitus, reproductive system abnormalities, anal atresia and Williams syndrome, eye disorders)
- History of preoperative cerebral ischemia and hypoxia
- Concurrent participation in other clinical trials
- Refusal of the family to sign the informed consent form or poor compliance by the child
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CBT group
The intervention group received a short intensive cognitive-behavioral therapy (CBT) intervention 7-14 days before surgery
|
After enrollment in the experimental group, the guardians were asked to fill out a sleep diary every day before surgery to self-report the children's sleep, and to wear a somatic movement recorder to monitor sleep (non-dominant arm) (wGT3x-BT accelerometer, ActiGraph) during the preoperative hospitalization period, except during surgery, and then to wear it to record the sleep-related parameters until 7 days after surgery or before discharge from the hospital.Preoperative daily cognitive-behavioral interventions (developmental trials were guided with WeChat applets), including cognitive change, sleep hygiene, sleep restriction, stimulus control, and relaxation training
|
|
No Intervention: control group
no intervention was imposed on the control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The incidence of postoperative delirium
Time Frame: Postoperative 7 days
|
Postoperative 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of postoperative Liver dysfunction
Time Frame: Postoperative 7 days
|
Postoperative 7 days
|
|
|
The incidence of postoperative Acute kidney injury
Time Frame: Within postoperative 7 days
|
Within postoperative 7 days
|
|
|
The incidence of Pulmonary complication
Time Frame: Postoperative 7 days
|
Postoperative 7 days
|
|
|
Types and dosages of drugs used for postoperative sedation and analgesia
Time Frame: Postoperative 7 days or before discharge
|
Postoperative 7 days or before discharge
|
|
|
The length of intensive care unit stay
Time Frame: From the end of the surgery to discharge from the hospital,up to 30 days
|
The time spent in the intensive care unit.
|
From the end of the surgery to discharge from the hospital,up to 30 days
|
|
The length of postoperative hospital stay
Time Frame: From the end of the surgery to the day of discharge from the hospital,up to 30 days
|
From the end of the surgery to the day of discharge from the hospital,up to 30 days
|
|
|
Average daily cost
Time Frame: admission to discharge, up to 30days
|
total hospitalization cost divided by total length of stay
|
admission to discharge, up to 30days
|
|
Concentration of intestinal fatty acid binding protein (I-FABP)
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
one of markers of intestinal injury
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
Concentration of zonulin
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
One of markers of intestinal injury
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
Concentration of lipopolysaccharide (LPS)
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
one of markers of intestinal injury
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
Concentration of lipopolysaccharide binding protein (LBP)
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
One of markers of intestinal injury
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
Concentration of IL-6
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
|
Concentration of TNF-α
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
|
Concentration of IL-1β
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
|
Concentration of IFN-γ
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
|
Concentration of IL-17
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
|
Concentration of C-reactive protein
Time Frame: before surgery, at the end of surgery and 24 hours after surgery
|
before surgery, at the end of surgery and 24 hours after surgery
|
|
|
The duration of postoperative mechanical ventilation
Time Frame: From the end of the surgery to the removal of the tracheal intubation,up to 30days
|
From the end of the surgery to the removal of the tracheal intubation,up to 30days
|
|
|
Mechanistic endpoint: Concentration of plasma S-100β protein
Time Frame: Before surgery, at the end of surgery and 24 hours after surgery
|
S-100β protein was used as a surrogate biomarker for the disruption of the blood-brain barrier.
|
Before surgery, at the end of surgery and 24 hours after surgery
|
|
Pain defined by the Wong-Baker faces pain scale (revision)
Time Frame: Postoperative 7 days
|
The Faces Pain Scale-Revised (FPS-R) requires patients to rate their overall pain intensity on a scale from 0 (no pain) to 10 (worst possible pain).
Simultaneously, the FPS-R provides six cartoon illustrations of facial expressions (ranging from smiling, sad, to agonized crying) to visually represent the pain levels corresponding to different score ranges.
This design aligns with children's concrete thinking characteristics.
During assessment, the child simply points to the numerical rating or cartoon face that best matches their perceived pain intensity, making it particularly suitable for children aged 4 to 12 years.
|
Postoperative 7 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Long-term Sleep quality score
Time Frame: 30 days, six months, 1 year postoperatively
|
guardians scored sleep quality 1-5 using a sleep diary
|
30 days, six months, 1 year postoperatively
|
|
Strengths and Difficulties Questionnaire Score
Time Frame: 6 months and 1 year after surgery
|
The Strengths and Difficulties Questionnaire (SDQ) consists of 25 items (0-50 scores) assessing five main domains: emotional symptoms, behavioral problems, oppositional behaviors, peer relationship problems, and social competence.
These dimensions allow researchers to get a comprehensive picture of a child's emotional and behavioral status, with higher scores being more severe.
Guardians will be required to complete the electronic SDQ Parent Version Questionnaire at 6 months postoperatively and 1 year postoperatively
|
6 months and 1 year after surgery
|
|
Readmission rate
Time Frame: 30 days,6 months,1 year after discharge
|
the rate at which a patient is readmitted to the hospital for the same or a different health problem within 30 days/six months/1 year after discharge
|
30 days,6 months,1 year after discharge
|
|
1-year mortality
Time Frame: 1 year after surgery
|
the death rate of 1 year after surgery
|
1 year after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fuxia Yan, Chinese Academy of Medical Sciences, Fuwai Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Cardiovascular Diseases
- Mental Disorders
- Postoperative Complications
- Pathologic Processes
- Confusion
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Sleep Wake Disorders
- Congenital Abnormalities
- Cardiovascular Abnormalities
- Emergence Delirium
- Delirium
- Dyssomnias
- Parasomnias
- Heart Diseases
- Heart Defects, Congenital
Other Study ID Numbers
- 2025-2602
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease (CHD)
-
The Children's Hospital of Zhejiang University...Beijing Children's Hospital; Children's Hospital of Nanjing Medical UniversityNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD)China
-
Ottawa Heart Institute Research CorporationUniversity of Ottawa Heart Institute, CanadaRecruitingCongenital Heart Disease (CHD)Canada
-
Assiut UniversityNot yet recruitingCongenital Heart Disease (CHD)Egypt
-
Carelon ResearchNot yet recruitingCongenital Heart Disease (CHD)United States
-
Carelon ResearchNot yet recruitingCongenital Heart Disease (CHD)United States
-
University Hospital, BordeauxNot yet recruiting
-
University Hospital, BordeauxRecruiting
-
The Hospital for Sick ChildrenCompletedCongenital Heart Disease (CHD)Canada
-
University College, LondonSociety for Cardiothoracic Surgery in Great Britain & Ireland; British Congenital...Unknown
-
University Hospital, BordeauxNot yet recruitingCHD - Congenital Heart DiseaseFrance
Clinical Trials on cognitive-behavioral intervention
-
Adai Technology (Beijing) Co., Ltd.CompletedDepression | AnxietyChina
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedDiabetes Mellitus, Type 2United States
-
Universidad de GranadaCompletedStress, Psychological | Vision Disorders | Self Efficacy | PsychopathySpain
-
Treatment Research InstituteNational Institute on Drug Abuse (NIDA)Completed
-
Rotterdam University of Applied SciencesVU University of Amsterdam; Multiple primary care physical therapy clinicsCompletedNeck PainNetherlands
-
Azienda Ospedaliera Universitaria Integrata VeronaSuspended
-
Wenzhou Medical UniversityWuhan University; Second Affiliated Hospital, School of Medicine, Zhejiang... and other collaboratorsCompletedDepression | Breast Cancer | AnxietyChina
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedHIV InfectionsUnited States
-
Waukesha Memorial HospitalUnknownMedication ErrorsUnited States
-
Soroka University Medical CenterThe Leona M. and Harry B. Helmsley Charitable TrustCompleted